Traditionally, this quest was fueled by the singular goal of identifying the genetic aberrations exhibiting similar causal relationships in other cancer types; however, it became readily apparent that this cause (BCR:ABL) and effect (chronic myelogenous leukemia) relationship was more an exception than the rule. The gene discussed is BCR; the disease is cancer.